Is SciSparc Ltd. (SPRC) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.5% / 30% | 65.3% / 30% | 157.6% / 30% | 32.24% / 5% | ✗ NOT HALAL |
| DJIM | 1.5% / 33% | 65.3% / 33% | 157.6% / 33% | 32.24% / 5% | ✗ NOT HALAL |
| MSCI | 0.4% / 33% | 19.9% / 33% | 48.0% / 33% | 32.24% / 5% | ✗ NOT HALAL |
| S&P | 1.5% / 33% | 65.3% / 33% | 157.6% / 33% | 32.24% / 5% | ✗ NOT HALAL |
| FTSE | 0.4% / 33% | 19.9% / 33% | 48.0% / 50% | 32.24% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 38.7% | |
| Operating Margin | -569.5% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -1281.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$5M |
| Free Cash Flow | -$5M |
| Total Debt | $46,000 |
| Total Assets | $10M |
Price & Trading
| Last Close | $3.99 |
| 50-Day MA | $5.81 |
| 200-Day MA | $28.57 |
| Avg Volume | 194K |
| Beta | 1.3 |
|
52-Week Range
$3.60
| |
About SciSparc Ltd. (SPRC)
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110, palmitoylethanolamide oral tablets and CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is SciSparc Ltd. (SPRC) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), SciSparc Ltd. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is SciSparc Ltd.'s debt ratio?
SciSparc Ltd.'s debt ratio is 1.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.4%.
What are SciSparc Ltd.'s key financial metrics?
SciSparc Ltd. has a market capitalization of $2M, trailing P/E ratio of 0.0, and revenue of $1M. Return on equity stands at -1281.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.